Skip to Main Content

Author Details

Daniel G Tenen
Harvard Stem Cell Institute, Harvard Medical School
1975
365
105
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36796022Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis.Blood2023
37749326APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints.Nat Immunol2023
37918959E4F1 and ZNF148 are transcriptional activators of the -57A &gt; C and wild-type <i>TERT</i> promoter.Genome Res2023
37461690SALL4B, not targeted by IMiD, is important for SALL4-mediated tumorigenesis.bioRxiv2023
36796022Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis.Blood2023
37495702Author Correction: A single-cell atlas of human and mouse white adipose tissue.Nature2023
36916958TIP60 is required for tumorigenesis in non-small cell lung cancer.Cancer Sci2023
37918959E4F1 and ZNF148 are transcriptional activators of the -57A &gt; C and wild-type <i>TERT</i> promoter.Genome Res2023
37749326APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints.Nat Immunol2023
37495702Author Correction: A single-cell atlas of human and mouse white adipose tissue.Nature2023
37461690SALL4B, not targeted by IMiD, is important for SALL4-mediated tumorigenesis.bioRxiv2023
36916958TIP60 is required for tumorigenesis in non-small cell lung cancer.Cancer Sci2023
35263572Response to NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation.Stem Cell Reports2022
35840577Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.Nat Commun2022
36010677SALL4: An Intriguing Therapeutic Target in Cancer Treatment.Cells2022
35427766EGFR signaling pathway as therapeutic target in human cancers.Semin Cancer Biol2022
36269860Long noncoding RNA-mediated activation of PROTOR1/PRR5-AKT signaling shunt downstream of PI3K in triple-negative breast cancer.Proc Natl Acad Sci U S A2022
35613022Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy.N Engl J Med2022
35551192Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.Nat Commun2022
35411071Non-coding RNA LEVER sequestration of PRC2 can mediate long range gene regulation.Commun Biol2022
35296864A single-cell atlas of human and mouse white adipose tissue.Nature2022
34854833Diverse functions of long noncoding RNAs in acute myeloid leukemia: emerging roles in pathophysiology, prognosis, and treatment resistance.Curr Opin Hematol2022
34965583ChIP-AP: an integrated analysis pipeline for unbiased ChIP-seq analysis.Brief Bioinform2022
34965583ChIP-AP: an integrated analysis pipeline for unbiased ChIP-seq analysis.Brief Bioinform2022
35263572Response to NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation.Stem Cell Reports2022
35551192Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.Nat Commun2022
35411071Non-coding RNA LEVER sequestration of PRC2 can mediate long range gene regulation.Commun Biol2022
35613022Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy.N Engl J Med2022
35840577Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.Nat Commun2022
35427766EGFR signaling pathway as therapeutic target in human cancers.Semin Cancer Biol2022
36269860Long noncoding RNA-mediated activation of PROTOR1/PRR5-AKT signaling shunt downstream of PI3K in triple-negative breast cancer.Proc Natl Acad Sci U S A2022
36010677SALL4: An Intriguing Therapeutic Target in Cancer Treatment.Cells2022
34854833Diverse functions of long noncoding RNAs in acute myeloid leukemia: emerging roles in pathophysiology, prognosis, and treatment resistance.Curr Opin Hematol2022
34965583ChIP-AP: an integrated analysis pipeline for unbiased ChIP-seq analysis.Brief Bioinform2022
34965583ChIP-AP: an integrated analysis pipeline for unbiased ChIP-seq analysis.Brief Bioinform2022
35296864A single-cell atlas of human and mouse white adipose tissue.Nature2022
33444684Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines.Gene2021
34242616Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma.Stem Cell Reports2021
34078745Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice.Sci Transl Med2021
33971010Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML.Blood2021
33971010Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML.Blood2021
33914855Chronic interleukin-1 exposure triggers selection for Cebpa-knockout multipotent hematopoietic progenitors.J Exp Med2021
34120146Metabolic alterations mediated by STAT3 promotes drug persistence in CML.Leukemia2021
34120146Metabolic alterations mediated by STAT3 promotes drug persistence in CML.Leukemia2021
33854168Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer.Commun Biol2021
34010414Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter.Blood2021
33884376The Interplay between Transcription Factor SALL4 and Histone Modifiers in Hematopoietic Stem and Progenitor Cells.J Cell Immunol2021
34038712Neurotensin is an anti-thermogenic peptide produced by lymphatic endothelial cells.Cell Metab2021
33444684Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines.Gene2021
33821975Emerging therapies for inv(16) AML.Blood2021
  • 1 - 50 of 730

Recommended Authors

Sasan Zandi
University of Toronto
Career Start Year 2006
Number of shared co-authors 2
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 7
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 2
Huafeng Xie
South China University of Technology
Career Start Year 2003
Number of shared co-authors 5
Andreas Lennartsson
Karolinska Institute
Career Start Year 2003
Number of shared co-authors 3
Hans-J??rg Warnatz
Max Planck Institute for Molecular Genetics
Career Start Year 2002
Number of shared co-authors 3
Sergei Doulatov
University of Washington
Career Start Year 2002
Number of shared co-authors 3
Wendy Dubois
Center for Cancer Research, National Cancer Institute
Career Start Year 2000
Number of shared co-authors 0
Jalila Chagraoui
Institute for Research in Immunology and Cancer, University of Montreal
Career Start Year 2000
Number of shared co-authors 3
Shinichiro Takahashi
Tohoku Medical and Pharmaceutical University Hospital.
Career Start Year 1998
Number of shared co-authors 0
Kevin S Smith
Stanford University
Career Start Year 1997
Number of shared co-authors 1
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 3
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 2
Michael Rehli
University Hospital Regensburg
Career Start Year 1995
Number of shared co-authors 9
Mikael Sigvardsson
Lund University, Linkoping University. .
Career Start Year 1993
Number of shared co-authors 4
Timothy A Graubert
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 8
Jan Willem Voncken
Maastricht University
Career Start Year 1992
Number of shared co-authors 0
Jana Krosl
The Leucegene Project at Institute for Research in Immunology and Cancer.
Career Start Year 1989
Number of shared co-authors 3
Geoffrey Neale
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 2
Guy Sauvageau
Universite de Montreal
Career Start Year 1988
Number of shared co-authors 9
Kristian Helin
The Institute of Cancer Research
Career Start Year 1988
Number of shared co-authors 6
Takuro Nakamura
Tohoku University Graduate School of Medicine
Career Start Year 1987
Number of shared co-authors 2
Tarik M??r??y
Institut de recherches cliniques de Montreal
Career Start Year 1985
Number of shared co-authors 3
Toshio Kitamura
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 5
Timothy J Ley
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 3
Michael C Ostrowski
Hollings Cancer Center, Medical University of South Carolina
Career Start Year 1979
Number of shared co-authors 1
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 4
Louise C Showe
The Wistar Institute
Career Start Year 1975
Number of shared co-authors 1
Bruce J Aronow
Cincinnati Children's Hospital Medical Center
Career Start Year 1975
Number of shared co-authors 2
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 6

Collaborators

Dong-Er Zhang
Moores Cancer Center, University of California San Diego
Co-authored papers 30
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Co-authored papers 24
Robert S Welner
University of Alabama at Birmingham
Co-authored papers 24
Mahmoud A Bassal
Cancer Science Institute of Singapore, National University of Singapore
Co-authored papers 16
Frank Rosenbauer
University Munster
Co-authored papers 15
Atsushi Iwama
Co-authored papers 14
Evan D Rosen
Co-authored papers 12
Matthew Meyerson
Broad Institute
Co-authored papers 7
Berthold Göttgens
Co-authored papers 7
Timothy C Burn
Incyte Research Institute
Co-authored papers 7
Pasi A J??nne
Dana-Farber Cancer Institute
Co-authored papers 6
Donna Neuberg
Co-authored papers 6
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 5
Dietger Niederwieser
University of Leipzig
Co-authored papers 4
Stefano Monti
Co-authored papers 4
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 4
John L Rinn
Co-authored papers 4
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 3
Sweta B Patel
The University of Alabama at Birmingham School of Medicine
Co-authored papers 3
Wolfgang E Berdel
University Hospital Munster
Co-authored papers 3
Vasileios Stathias
Co-authored papers 3
Tune H Pers
Co-authored papers 3
Alex Look
Dana-Farber Cancer Institute
Co-authored papers 3
Yoshiaki Ito
Tokyo Medical and Dental University (TMDU)
Co-authored papers 3
Francisco Vega
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Stephan C Sch??rer
Institute for Data Science and Computing, University of Miami
Co-authored papers 3
Jun Qi
Dana-Farber Cancer Institute
Co-authored papers 3
Roel G W Verhaak
Yale School of Medicine
Co-authored papers 3
Jihye Park
Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 3
Marzia Del Re
University of Pisa
Co-authored papers 2
Release 1.2